Dare Bioscience develops women's health drugs and consumer products for areas such as contraception, menopause, and sexual health. It last closed at $0.41 on Nov 20, down 9.87% on the day. The next earnings report for DARE is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, DARE reported EPS of -$0.18 on revenue of $47,628, with revenue up 2005.6% from a year ago. Over its last 8 reports the stock moved an average of 11.7% the session after earnings. Over the last 12 months DARE insiders bought $0 of stock on the open market and sold $382, according to SEC Form 4 filings.
AI Auto Pilots
Is DARE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DARE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on DAREStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
DARE · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 51% below its 20 day and 73% below its 50 day average. It is 264% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the Pivot S1 at $0.38, and the nearest resistance the 52 week low at $0.41.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 15.8%/day
Key levels
$3.7852 week high+822.0%
$1.48200 day average+261.0%
$0.98100 day average+139.0%
$0.71Swing high (Nov 11)+73.2%
$0.7050 day average+70.7%
$0.6120 day average+48.8%
$0.46Pivot R1+12.2%
$0.43Pivot+4.9%
$0.4152 week low+0.0%
$0.41Last close
$0.38Pivot S1−7.3%
Indicators
RSI (14)
23.77
Oversold below 30
Oversold
MACD
-0.07
Below its signal line
Bearish
Stochastic
7.6
Near the bottom of its range
Oversold
ADX (14)
30.4
Trending down
Williams %R
-99.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-190.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−36.2%
Change over 10 sessions
Bearish
ATR (14)
$0.06
Typical daily range, 15.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 58.2%/day
Key levels
$3.7852 week high+822.0%
$1.48200 day average+261.0%
$0.98100 day average+139.0%
$0.71Swing high (Nov 11)+73.2%
$0.7050 day average+70.7%
$0.6120 day average+48.8%
$0.46Pivot R1+12.2%
$0.43Pivot+4.9%
$0.4152 week low+0.0%
$0.41Last close
$0.38Pivot S1−7.3%
Indicators
RSI (14)
29.98
Oversold below 30
Oversold
MACD
-0.32
Below its signal line
Bearish
Stochastic
2.6
Near the bottom of its range
Oversold
ADX (14)
20.1
Weak trend
Williams %R
-99.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-91.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−42.3%
Change over 10 sessions
Bearish
ATR (14)
$0.24
Typical daily range, 58.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DARE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how DARE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow DARE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for DAREHow many large options trades hit DARE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in DARE in the last 90 days.
From SEC Form 4 filings by DARE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DARE is in one of them and how their past DARE trades turned out.
Dare Bioscience is a biotech company based in San Diego, California, that develops products for women's health. Its portfolio covers areas such as contraception, menopause, sexual health, pelvic pain, fertility, and vaginal health. The company plans to offer prescription products, compounded drugs, and consumer health products that do not need a prescription, mainly for women and the healthcare providers who treat them. Its first FDA-approved product, a treatment for bacterial vaginosis, is licensed to another drugmaker for sale.